DNA modification

N6-mA condenses chromatin

Cell 175, 1228–1243 (2018)

Although the N6-methyladenine (N6-mA) DNA modification has been shown to exist within human genomic DNA, its biological function remains unclear. To investigate the role of N6-mA in glioblastoma, Xie et al. first showed that N6-mA was upregulated in human patient-derived glioblastoma stem cells (GSCs) and primary human tumor specimens. Genomic profiling revealed that N6-mA is distributed in intergenic regions and overlaps with heterochromatic histone modifications. Deletion of the N6-mA demethylase ALKBH1 increased N6-mA levels and decreased chromatin accessibility in GSCs. Sites with increased N6-mA modifications were found in ALKBH1-regulated genes associated with K3K9me3-containing heterochromatin regions, suggesting that ALKBH1 depletion promotes heterochromatin formation by increasing N6-mA levels to repress gene expression. Silencing ALKBH1 inhibited proliferation and the self-renewal ability of GSCs, as well as tumor growth in mice xenograft models. This study revealed the relationship between N6-mA and chromatin status and provided a potential therapeutic target for glioblastoma therapy.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yiyun Song.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Song, Y. N6-mA condenses chromatin. Nat Chem Biol 15, 2 (2019). https://doi.org/10.1038/s41589-018-0199-9

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing